Skip to content

Menu

Network Sub-MenuBrowse by SubjectBrowse by PublisherJoin the NetworkGet StartedSubscribeSupportContact

Search

Close

Enter Search Terms

Sean Anderson

ID: 1b83cc90-2619-30fb-68c4

/

Unclaimed

/

Organization: Goodwin Procter

Year in Review: Top Biosimilars-Related Regulatory Developments of 2022

Big Molecule Watch · December 31, 2022

Celltrion USA Announces Submission of BLA for Subcutaneous Infliximab Biosimilar

Big Molecule Watch · December 24, 2022

BPCIA Aflibercept Litigation: Regeneron Files 12(c) Motion to Dismiss Mylan’s Counterclaim for Inequitable Conduct

Big Molecule Watch · December 20, 2022

The UK’s MHRA Updates its Guidance on Licensing of Biosimilars

Big Molecule Watch · November 17, 2022

Celltrion Files IND with FDA for Adalimumab Biosimilar

Big Molecule Watch · August 5, 2022

Previous

12 3

Next

Claim This Record

Is this your profile? Upgrade to display your full biography, collected works, social connections, practice areas, and more.

Enhance Your Profile

Call us at 1-800-913-0988 or email sales@lexblog.com.

Facebook LinkedIn Twitter RSS

About LexBlog
The Field We Built
Library at LexBlog
Our Beliefs
Our Team
Contact LexBlog

Disclaimer
Editorial Policy
Terms of Service

Get Started
Publishing Solutions
Compass

Submit a Request
Support Center
System Status

Copyright © 2026, LexBlog, Inc. All Rights Reserved.

Law blog design & platform by LexBlog